In August, Zydus Cadila’s three-dose DNA jab was allowed to be used on adults and children over the age of 12. Covaxin will be administered in children in two doses, with a gap of 28 days between the first and second doses. The gap and dosage of vaccine for adults and children will be the same according to the trial data submitted to the government, News18 reported.
Medanta Chairman Dr Naresh Trehan welcomed the announcement and termed it as a big relief amid a surge in Omicron cases. “In view of Omicron rapidly spreading, it’s great news," he told News18. “It would help if the data were put out in public," he said.